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Background: Numerous randomized trials have demonstrated that drug-eluting stents (DES) reduce clinical and angiographic restenosis 
compared with bare metal stents (BMS) in 2.5-3.5 mm diameter coronary arteries . The benefits of DES in large (≥3.5mm) diameter coronary 
arteries are less well established, however.
Methods: We used data from the multicenter EVENT registry to compare clinical outcomes among patients undergoing PCI with either DES 
(n=1557) or BMS (n=338) for lesions with reference diameters 3.5-5.0 mm. The primary endpoint was the composite of death, myocardial infarction 
(MI), or target lesion revascularization (TLR) at 1 year. Propensity stratification was used to adjust for baseline differences between groups.
Results: Although most patient charcteristics were similar, BMS pts were more likely to have presented with STEMI (15.2% v. 8.5%). Maximum 
balloon diameters were larger in the BMS group, whereas the DES group underwent more bifurcation stenting (10.6% vs 5.2%) and had longer total 
stent lengths (22.9mm vs 21.1mm). Both in-hospital and 1-year clinical outcomes were comparable between the DES and BMS groups (see Table). 
Similar results were observed in risk-adjusted analyses as well. 
Patients with
BMS only
(N=328)
Patients with
DES only
(N=1557)
P-value
In-Hospital Outcome
MACE (Death/MI/Urgent Repeat PCI or CABG) 7.0% (23/328) 6.7% (104/1557) 0.827
Death/MI 6.1% (20/328) 6.6% (102/1557) 0.762
Death 0.0% (0/328) 0.1% (2/1557) 0.516
Urgent Repeat PCI or CABG 0.9% (3/328) 0.4% (6/1557) 0.206
Stent Thrombosis 0.0% (0/328) 0.1% (2/1557) 0.516
1-Year Outcome
MACE (Death/MI/TLR) 13.0% (41/315) 11.3% (167/1476) 0.392
Death/MI 9.5% (30/315) 9.0% (133/1476) 0.774
Death 1.3% (4/315) 1.2% (17/1476) 0.860
TVR 5.1% (16/315) 4.7% (70/1476) 0.800
TLR 4.8% (15/315) 3.2% (47/1476) 0.164
Stent Thrombosis 0.0% (0/315) 0.5% (7/1476) 0.221
Conclusion: In native coronary arteries ≥ 3.5mm diameter, there was little clinical benefit of DES over BMS over the first year of follow-up with a 
non significant increase in stent thrombosis.
